€1M Grant from Bpifrance’s Innovation Prize
February 20, 2019
Proud Laureate of the PhD Paris Region Funding Initiative
June 21, 2019
March 22, 2019
[EVENTS] Company ; METAglut1™
We had the honor of presenting at the 47th Annual Meeting of the Société Européenne de Neurologie Pédiatrique (SENP), a key event dedicated to advancing the field of pediatric neurology in Europe.
This gathering brought together leading experts and practitioners in pediatric neurology to discuss the latest research and advancements in the field.
We were particularly proud to have the intermediate results of our validation study for METAglut1™ presented by Dr. Odile Boespflug-Tanguy, a neuropediatrician from the AP-HP Paris Region Hospitals (Assistance-Publique – Hôîtaux de Paris).
POSTER PRESENTATION:
“Evaluating the performance of METAglut1 in patients whose clinical presentation is compatible with the glucose transporter 1 deficiency syndrome (Glut1-DS)“
METAglut1™ is our first IVD blood test to aid the early diagnosis of Glut1 Deficiency Syndrom (Glut1DS), also known as De Vivo Disease, a rare metabolic disorder that can significantly impact the lives of affected children.
Sharing our intermediate results at the meeting of SeNP 2019 has invigorated our commitment to advancing research and innovation in pediatric health. We are dedicated to collaborating with experts and stakeholders to improve patient outcomes and have the test as fast as possible covered and available.
